Skip to Main Content
Phase III

Humacyte ATEV Study

  • Study HIC#:2000036362
  • Last Updated:12/15/2025

This study is looking to see how effective an investigational product (ATEV) is in women with end-stage kidney disease needing hemodialysis. The study compares the ATEV with an arteriovenous fistula for use in hemodialysis.

  • Age18 years and older
  • GenderFemale only

Contact Us

For more information about this study, including how to volunteer, contact:

Sara Niesobecki

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call +18779788343 for more information.

Eligibility Criteria

Female patients with end-stage renal disease currently receiving hemodialysis via catheter who are candidates for the creation of an arteriovenous fistula or graft for dialysis access.

For more information about this study, including how to volunteer, contact: